General MedicationsINJECTIONGeneric
POTASSIUM CHLORIDE
POTASSIUM CHLORIDE
Standard Dose
2.4MEQ/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview POTASSIUM CHLORIDE is listed in Drugs@FDA under application 080205 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient POTASSIUM CHLORIDE Form and strength INJECTABLE;INJECTION - 2.4MEQ/ML Sponsor HOSPIRA Submission history Latest submission status date: 2022-12-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview POTASSIUM CHLORIDE is listed in Drugs@FDA under application 080205 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient POTASSIUM CHLORIDE Form and strength INJECTABLE;INJECTION - 2.4MEQ/ML Sponsor HOSPIRA Submission history Latest submission status date: 2022-12-02 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.